SCHEMBL323668

SCHEMBL323668

C[C](c1ccccn1)C1CCCC1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.50
PKM P14618 2/20 0.49
KDM4E B2RXH2 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.45
RAB9A P51151 2/20 0.45
NPC1 O15118 1/20 0.45
LMNA P02545 2/20 0.44
GRM5 P41594 1/20 0.44
CES2 O00748 1/20 0.44
CES1 P23141 1/20 0.44
L3MBTL1 Q9Y468 3/20 0.42
NAPRT Q6XQN6 1/20 0.42
P4HTM Q9NXG6 1/20 0.42
GAA P10253 2/20 0.42
CYP1A2 P05177 1/20 0.42
GRM4 Q14833 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2C9 P11712 1/20 0.42
ADORA3 P0DMS8 1/20 0.40
EPHX2 P34913 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1848757 0.79 PKM (0.50) ALDH1A1PKMSMN1; SMN2RAB9ANPC1
SCHEMBL6449861 0.78 CYP3A4 (0.58) ALDH1A1PKMSMN1; SMN2RAB9ANPC1
SCHEMBL4458878 0.76 PKM (0.58) ALDH1A1PKMSMN1; SMN2RAB9ANPC1
SCHEMBL5042317 0.74 CYP3A4 (0.58) ALDH1A1PKMSMN1; SMN2RAB9ANPC1
SCHEMBL38661039 0.74 CES2 (0.58) ALDH1A1PKMSMN1; SMN2RAB9ANPC1
SCHEMBL6714110 0.73 KDM4E (0.54) ALDH1A1PKMKDM4ESMN1; SMN2RAB9A
SCHEMBL6714109 0.73 KDM4E (0.54) ALDH1A1PKMKDM4ESMN1; SMN2RAB9A
SCHEMBL15364436 0.71 GRM5 (0.45) ALDH1A1PKMKDM4ESMN1; SMN2RAB9A
SCHEMBL9843696 0.71 HPGD (0.48) ALDH1A1PKMKDM4ESMN1; SMN2RAB9A
SCHEMBL1515056 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2590981-B1 NOVEL HOMOPIPERAZINE DERIVATIVES AS PROTEIN TYROSINE KINASE INHIBITORS AND PHARMACEUTICAL USE THEREOF LEO PHARMA AS (DK) 2014-09-03 EP claimed
EP-2590981-A1 NOVEL HOMOPIPERAZINE DERIVATIVES AS PROTEIN TYROSINE KINASE INHIBITORS AND PHARMACEUTICAL USE THEREOF Leo Pharma A/S (DK) 2013-05-15 EP claimed
WO-2012003829-A1 NOVEL HOMOPIPERAZINE DERIVATIVES AS PROTEIN TYROSINE KINASE INHIBITORS AND PHARMACEUTICAL USE THEREOF LEO PHARMA A/S (DK) 2012-01-12 WO claimed
EP-2590981-B1 NOVEL HOMOPIPERAZINE DERIVATIVES AS PROTEIN TYROSINE KINASE INHIBITORS AND PHARMACEUTICAL USE THEREOF LEO PHARMA AS (DK) 2014-09-03 EP disclosed
EP-2590981-A1 NOVEL HOMOPIPERAZINE DERIVATIVES AS PROTEIN TYROSINE KINASE INHIBITORS AND PHARMACEUTICAL USE THEREOF Leo Pharma A/S (DK) 2013-05-15 EP disclosed
WO-2012003829-A1 NOVEL HOMOPIPERAZINE DERIVATIVES AS PROTEIN TYROSINE KINASE INHIBITORS AND PHARMACEUTICAL USE THEREOF LEO PHARMA A/S (DK) 2012-01-12 WO disclosed